HEADER TRANSFERASE 14-NOV-08 3F9N TITLE CRYSTAL STRUCTURE OF CHK1 KINASE IN COMPLEX WITH INHIBITOR 38 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE CHK1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CHK1 KINASE DOMAIN: UNP RESIDUES 2-307; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 GENE: CHEK1, CHK1; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PRAD2030 KEYWDS CHEK1, CHK1, KINASE, CELL CYCLE CHECKPOINT, ATP-BINDING, CYTOPLASM, KEYWDS 2 DNA DAMAGE, DNA REPAIR, NUCLEOTIDE-BINDING, NUCLEUS, PHOSPHOPROTEIN, KEYWDS 3 POLYMORPHISM, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, UBL KEYWDS 4 CONJUGATION EXPDTA X-RAY DIFFRACTION AUTHOR Y.YAN,S.MUNSHI,M.IKUTA REVDAT 3 06-SEP-23 3F9N 1 REMARK SEQADV REVDAT 2 28-APR-09 3F9N 1 JRNL REVDAT 1 20-JAN-09 3F9N 0 JRNL AUTH A.CONVERSO,T.HARTINGH,R.M.GARBACCIO,E.TASBER,K.RICKERT, JRNL AUTH 2 M.E.FRALEY,Y.YAN,C.KREATSOULAS,S.STIRDIVANT,B.DRAKAS, JRNL AUTH 3 E.S.WALSH,K.HAMILTON,C.A.BUSER,X.MAO,M.T.ABRAMS,S.C.BECK, JRNL AUTH 4 W.TAO,R.LOBELL,L.SEPP-LORENZINO,J.ZUGAY-MURPHY,V.SARDANA, JRNL AUTH 5 S.K.MUNSHI,S.M.JEZEQUEL-SUR,P.D.ZUCK,G.D.HARTMAN JRNL TITL DEVELOPMENT OF THIOQUINAZOLINONES, ALLOSTERIC CHK1 KINASE JRNL TITL 2 INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 19 1240 2009 JRNL REFN ISSN 0960-894X JRNL PMID 19155174 JRNL DOI 10.1016/J.BMCL.2008.12.076 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 26375 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.216 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 1326 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 9 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.01 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.94 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 4273 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2074 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4039 REMARK 3 BIN R VALUE (WORKING SET) : 0.2047 REMARK 3 BIN FREE R VALUE : 0.2546 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.48 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 234 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2064 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 47 REMARK 3 SOLVENT ATOMS : 257 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.26 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.68696 REMARK 3 B22 (A**2) : 4.04991 REMARK 3 B33 (A**2) : -6.73688 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.98765 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2168 ; 2.000 ; NULL REMARK 3 BOND ANGLES : 2923 ; 2.000 ; NULL REMARK 3 TORSION ANGLES : 482 ; 0.000 ; NULL REMARK 3 TRIGONAL CARBON PLANES : 71 ; 2.000 ; NULL REMARK 3 GENERAL PLANES : 303 ; 5.000 ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : 2168 ; 20.000 ; NULL REMARK 3 BAD NON-BONDED CONTACTS : 42 ; 5.000 ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.08 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3F9N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-NOV-08. REMARK 100 THE DEPOSITION ID IS D_1000050320. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-AUG-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : CONFOCAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26390 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.06600 REMARK 200 R SYM (I) : 0.06600 REMARK 200 FOR THE DATA SET : 18.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.38300 REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: BUSTER-TNT REMARK 200 STARTING MODEL: PDB ENTRY 1IA8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 13% PEG 8000, 0.1M AMMONIUM SULFATE, REMARK 280 2% GLYCEROL, 0.1M CACODYLATE BUFFER PH 6.8, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 32.87500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 2 REMARK 465 VAL A 3 REMARK 465 PRO A 4 REMARK 465 PHE A 5 REMARK 465 VAL A 6 REMARK 465 GLU A 17 REMARK 465 GLY A 18 REMARK 465 ALA A 19 REMARK 465 TYR A 20 REMARK 465 ARG A 44 REMARK 465 ALA A 45 REMARK 465 VAL A 46 REMARK 465 ASP A 47 REMARK 465 CYS A 48 REMARK 465 PRO A 49 REMARK 465 GLU A 50 REMARK 465 LYS A 271 REMARK 465 GLY A 272 REMARK 465 ALA A 273 REMARK 465 LYS A 274 REMARK 465 ARG A 275 REMARK 465 PRO A 276 REMARK 465 ARG A 277 REMARK 465 VAL A 278 REMARK 465 THR A 279 REMARK 465 SER A 280 REMARK 465 GLY A 281 REMARK 465 GLY A 282 REMARK 465 VAL A 283 REMARK 465 SER A 284 REMARK 465 GLU A 285 REMARK 465 SER A 286 REMARK 465 PRO A 287 REMARK 465 SER A 288 REMARK 465 GLY A 289 REMARK 465 PHE A 290 REMARK 465 SER A 291 REMARK 465 LYS A 292 REMARK 465 HIS A 293 REMARK 465 ILE A 294 REMARK 465 GLN A 295 REMARK 465 SER A 296 REMARK 465 ASN A 297 REMARK 465 LEU A 298 REMARK 465 ASP A 299 REMARK 465 PHE A 300 REMARK 465 SER A 301 REMARK 465 PRO A 302 REMARK 465 VAL A 303 REMARK 465 ASN A 304 REMARK 465 SER A 305 REMARK 465 ALA A 306 REMARK 465 SER A 307 REMARK 465 ARG A 308 REMARK 465 THR A 309 REMARK 465 PRO A 310 REMARK 465 GLY A 311 REMARK 465 SER A 312 REMARK 465 GLY A 313 REMARK 465 TRP A 314 REMARK 465 SER A 315 REMARK 465 LYS A 316 REMARK 465 GLU A 317 REMARK 465 HIS A 318 REMARK 465 HIS A 319 REMARK 465 HIS A 320 REMARK 465 HIS A 321 REMARK 465 HIS A 322 REMARK 465 HIS A 323 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 8 136.35 121.75 REMARK 500 ASP A 41 80.60 -68.19 REMARK 500 MET A 42 -18.09 -45.17 REMARK 500 ASN A 63 94.41 -161.38 REMARK 500 ARG A 74 113.45 -160.27 REMARK 500 ASP A 99 -8.45 73.07 REMARK 500 ARG A 129 -2.23 73.24 REMARK 500 ASP A 130 45.22 -147.20 REMARK 500 ASP A 148 93.52 73.21 REMARK 500 ASN A 165 -12.79 -143.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 38M A 324 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 402 DBREF 3F9N A 2 307 UNP O14757 CHK1_HUMAN 2 307 SEQADV 3F9N ARG A 308 UNP O14757 EXPRESSION TAG SEQADV 3F9N THR A 309 UNP O14757 EXPRESSION TAG SEQADV 3F9N PRO A 310 UNP O14757 EXPRESSION TAG SEQADV 3F9N GLY A 311 UNP O14757 EXPRESSION TAG SEQADV 3F9N SER A 312 UNP O14757 EXPRESSION TAG SEQADV 3F9N GLY A 313 UNP O14757 EXPRESSION TAG SEQADV 3F9N TRP A 314 UNP O14757 EXPRESSION TAG SEQADV 3F9N SER A 315 UNP O14757 EXPRESSION TAG SEQADV 3F9N LYS A 316 UNP O14757 EXPRESSION TAG SEQADV 3F9N GLU A 317 UNP O14757 EXPRESSION TAG SEQADV 3F9N HIS A 318 UNP O14757 EXPRESSION TAG SEQADV 3F9N HIS A 319 UNP O14757 EXPRESSION TAG SEQADV 3F9N HIS A 320 UNP O14757 EXPRESSION TAG SEQADV 3F9N HIS A 321 UNP O14757 EXPRESSION TAG SEQADV 3F9N HIS A 322 UNP O14757 EXPRESSION TAG SEQADV 3F9N HIS A 323 UNP O14757 EXPRESSION TAG SEQRES 1 A 322 ALA VAL PRO PHE VAL GLU ASP TRP ASP LEU VAL GLN THR SEQRES 2 A 322 LEU GLY GLU GLY ALA TYR GLY GLU VAL GLN LEU ALA VAL SEQRES 3 A 322 ASN ARG VAL THR GLU GLU ALA VAL ALA VAL LYS ILE VAL SEQRES 4 A 322 ASP MET LYS ARG ALA VAL ASP CYS PRO GLU ASN ILE LYS SEQRES 5 A 322 LYS GLU ILE CYS ILE ASN LYS MET LEU ASN HIS GLU ASN SEQRES 6 A 322 VAL VAL LYS PHE TYR GLY HIS ARG ARG GLU GLY ASN ILE SEQRES 7 A 322 GLN TYR LEU PHE LEU GLU TYR CYS SER GLY GLY GLU LEU SEQRES 8 A 322 PHE ASP ARG ILE GLU PRO ASP ILE GLY MET PRO GLU PRO SEQRES 9 A 322 ASP ALA GLN ARG PHE PHE HIS GLN LEU MET ALA GLY VAL SEQRES 10 A 322 VAL TYR LEU HIS GLY ILE GLY ILE THR HIS ARG ASP ILE SEQRES 11 A 322 LYS PRO GLU ASN LEU LEU LEU ASP GLU ARG ASP ASN LEU SEQRES 12 A 322 LYS ILE SER ASP PHE GLY LEU ALA THR VAL PHE ARG TYR SEQRES 13 A 322 ASN ASN ARG GLU ARG LEU LEU ASN LYS MET CYS GLY THR SEQRES 14 A 322 LEU PRO TYR VAL ALA PRO GLU LEU LEU LYS ARG ARG GLU SEQRES 15 A 322 PHE HIS ALA GLU PRO VAL ASP VAL TRP SER CYS GLY ILE SEQRES 16 A 322 VAL LEU THR ALA MET LEU ALA GLY GLU LEU PRO TRP ASP SEQRES 17 A 322 GLN PRO SER ASP SER CYS GLN GLU TYR SER ASP TRP LYS SEQRES 18 A 322 GLU LYS LYS THR TYR LEU ASN PRO TRP LYS LYS ILE ASP SEQRES 19 A 322 SER ALA PRO LEU ALA LEU LEU HIS LYS ILE LEU VAL GLU SEQRES 20 A 322 ASN PRO SER ALA ARG ILE THR ILE PRO ASP ILE LYS LYS SEQRES 21 A 322 ASP ARG TRP TYR ASN LYS PRO LEU LYS LYS GLY ALA LYS SEQRES 22 A 322 ARG PRO ARG VAL THR SER GLY GLY VAL SER GLU SER PRO SEQRES 23 A 322 SER GLY PHE SER LYS HIS ILE GLN SER ASN LEU ASP PHE SEQRES 24 A 322 SER PRO VAL ASN SER ALA SER ARG THR PRO GLY SER GLY SEQRES 25 A 322 TRP SER LYS GLU HIS HIS HIS HIS HIS HIS HET 38M A 324 44 HET SO4 A 401 5 HET SO4 A 402 5 HETNAM 38M 3-(3-CHLOROPHENYL)-2-({(1S)-1-[(6S)-2,8- HETNAM 2 38M DIAZASPIRO[5.5]UNDEC-2-YLCARBONYL]PENTYL}SULFANYL) HETNAM 3 38M QUINAZOLIN-4(3H)-ONE HETNAM SO4 SULFATE ION FORMUL 2 38M C29 H35 CL N4 O2 S FORMUL 3 SO4 2(O4 S 2-) FORMUL 5 HOH *257(H2 O) HELIX 1 1 ASN A 51 MET A 61 1 11 HELIX 2 2 PHE A 93 ILE A 96 5 4 HELIX 3 3 PRO A 103 ILE A 124 1 22 HELIX 4 4 LYS A 132 GLU A 134 5 3 HELIX 5 5 THR A 170 VAL A 174 5 5 HELIX 6 6 ALA A 175 ARG A 181 1 7 HELIX 7 7 HIS A 185 GLY A 204 1 20 HELIX 8 8 CYS A 215 GLU A 223 1 9 HELIX 9 9 PRO A 230 ILE A 234 5 5 HELIX 10 10 ASP A 235 LEU A 246 1 12 HELIX 11 11 THR A 255 LYS A 260 1 6 SHEET 1 A 5 TRP A 9 GLY A 16 0 SHEET 2 A 5 GLU A 22 ASN A 28 -1 O LEU A 25 N GLN A 13 SHEET 3 A 5 ALA A 34 ASP A 41 -1 O VAL A 35 N ALA A 26 SHEET 4 A 5 ILE A 79 LEU A 84 -1 O GLN A 80 N VAL A 40 SHEET 5 A 5 PHE A 70 ARG A 74 -1 N TYR A 71 O PHE A 83 SHEET 1 B 3 GLY A 90 GLU A 91 0 SHEET 2 B 3 LEU A 136 LEU A 138 -1 O LEU A 138 N GLY A 90 SHEET 3 B 3 LEU A 144 ILE A 146 -1 O LYS A 145 N LEU A 137 SHEET 1 C 2 ILE A 126 THR A 127 0 SHEET 2 C 2 THR A 153 VAL A 154 -1 O THR A 153 N THR A 127 SHEET 1 D 2 ARG A 156 TYR A 157 0 SHEET 2 D 2 ARG A 160 GLU A 161 -1 O ARG A 160 N TYR A 157 CISPEP 1 ASN A 229 PRO A 230 0 -3.87 SITE 1 AC1 10 PHE A 93 ILE A 96 ASP A 99 PRO A 133 SITE 2 AC1 10 ALA A 200 GLY A 204 GLU A 205 LEU A 206 SITE 3 AC1 10 PRO A 207 HOH A 495 SITE 1 AC2 7 LYS A 54 ARG A 129 THR A 153 ARG A 162 SITE 2 AC2 7 LYS A 166 HOH A 413 HOH A 514 SITE 1 AC3 4 SER A 212 ASP A 213 SER A 214 HOH A 508 CRYST1 45.060 65.750 58.410 90.00 96.24 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022193 0.000000 0.002427 0.00000 SCALE2 0.000000 0.015209 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017222 0.00000